MedPath
TGA Approval

HUMIRA adalimumab 40 mg/0.4 mL solution for injection pre-filled syringe (281470)

281470

HUMIRA adalimumab 40 mg/0.4 mL solution for injection pre-filled syringe

AbbVie Pty Ltd

November 16, 2017

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/96c9e7fb0cab00b75b52c5656dd7e3ec.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/d99697291a8f3626839f543c084b2098.pdf

Active Ingredients

Adalimumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HUMIRA adalimumab 40 mg/0.4 mL solution for injection pre-filled syringe (281470) - TGA 批准文号 | MedPath